Cargando…

Axial length targets for myopia control

PURPOSE: Both emmetropic and myopic eyes elongate throughout childhood. The goals of this study were to compare axial elongation among untreated progressing myopes, progressing myopes treated with a myopia control contact lens and emmetropes, in order to place axial elongation in the context of norm...

Descripción completa

Detalles Bibliográficos
Autores principales: Chamberlain, Paul, Lazon de la Jara, Percy, Arumugam, Baskar, Bullimore, Mark A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252804/
https://www.ncbi.nlm.nih.gov/pubmed/33951213
http://dx.doi.org/10.1111/opo.12812
_version_ 1783717378920546304
author Chamberlain, Paul
Lazon de la Jara, Percy
Arumugam, Baskar
Bullimore, Mark A
author_facet Chamberlain, Paul
Lazon de la Jara, Percy
Arumugam, Baskar
Bullimore, Mark A
author_sort Chamberlain, Paul
collection PubMed
description PURPOSE: Both emmetropic and myopic eyes elongate throughout childhood. The goals of this study were to compare axial elongation among untreated progressing myopes, progressing myopes treated with a myopia control contact lens and emmetropes, in order to place axial elongation in the context of normal eye growth in emmetropic children, and to consider whether normal physiological eye growth places limits on what might be achieved with myopia control. METHODS: Axial elongation data were taken from the 3‐year randomised clinical trial of a myopia control dual‐focus (MiSight® 1 day) contact lens. These were compared with data for myopic and emmetropic children in two large cohort studies: the Orinda Longitudinal Study of Myopia (OLSM) and the Singapore Cohort Study of the Risk Factors for Myopia (SCORM). Each study's published equations were used to calculate annual axial elongation. Four virtual cohorts—myopic and emmetropic for each model—were created, each with the same age distribution as the MiSight clinical trial subjects and the predicted cumulative elongation calculated at years 1, 2 and 3 for myopes and emmetropes using both the OLSM and SCORM models. RESULTS: The untreated control myopes in the MiSight clinical trial showed mean axial elongation over 3 years (0.62 mm) similar to the virtual cohorts based on the OLSM (0.70 mm) and SCORM (0.65 mm) models. The predicted 3‐year axial elongation for the virtual cohorts of emmetropes was 0.24 mm for both the OLSM and SCORM models—similar to the mean 3‐year elongation in MiSight‐treated myopes (0.30 mm). CONCLUSIONS: The 3‐year elongation in MiSight‐treated myopes approached that of virtual cohorts of emmetropes with the same age distribution. It is hypothesised that myopic axial elongation is superimposed on an underlying physiological axial elongation observed in emmetropic eyes, which reflects increases in body stature. We speculate that optically based myopia control treatments may minimise the myopic axial elongation but retain the underlying physiological elongation observed in emmetropic eyes.
format Online
Article
Text
id pubmed-8252804
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82528042021-07-12 Axial length targets for myopia control Chamberlain, Paul Lazon de la Jara, Percy Arumugam, Baskar Bullimore, Mark A Ophthalmic Physiol Opt Feature Issue Manuscripts PURPOSE: Both emmetropic and myopic eyes elongate throughout childhood. The goals of this study were to compare axial elongation among untreated progressing myopes, progressing myopes treated with a myopia control contact lens and emmetropes, in order to place axial elongation in the context of normal eye growth in emmetropic children, and to consider whether normal physiological eye growth places limits on what might be achieved with myopia control. METHODS: Axial elongation data were taken from the 3‐year randomised clinical trial of a myopia control dual‐focus (MiSight® 1 day) contact lens. These were compared with data for myopic and emmetropic children in two large cohort studies: the Orinda Longitudinal Study of Myopia (OLSM) and the Singapore Cohort Study of the Risk Factors for Myopia (SCORM). Each study's published equations were used to calculate annual axial elongation. Four virtual cohorts—myopic and emmetropic for each model—were created, each with the same age distribution as the MiSight clinical trial subjects and the predicted cumulative elongation calculated at years 1, 2 and 3 for myopes and emmetropes using both the OLSM and SCORM models. RESULTS: The untreated control myopes in the MiSight clinical trial showed mean axial elongation over 3 years (0.62 mm) similar to the virtual cohorts based on the OLSM (0.70 mm) and SCORM (0.65 mm) models. The predicted 3‐year axial elongation for the virtual cohorts of emmetropes was 0.24 mm for both the OLSM and SCORM models—similar to the mean 3‐year elongation in MiSight‐treated myopes (0.30 mm). CONCLUSIONS: The 3‐year elongation in MiSight‐treated myopes approached that of virtual cohorts of emmetropes with the same age distribution. It is hypothesised that myopic axial elongation is superimposed on an underlying physiological axial elongation observed in emmetropic eyes, which reflects increases in body stature. We speculate that optically based myopia control treatments may minimise the myopic axial elongation but retain the underlying physiological elongation observed in emmetropic eyes. John Wiley and Sons Inc. 2021-05-05 2021-05 /pmc/articles/PMC8252804/ /pubmed/33951213 http://dx.doi.org/10.1111/opo.12812 Text en © 2021 The Authors. Ophthalmic and Physiological Optics published by John Wiley & Sons Ltd on behalf of College of Optometrists. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Feature Issue Manuscripts
Chamberlain, Paul
Lazon de la Jara, Percy
Arumugam, Baskar
Bullimore, Mark A
Axial length targets for myopia control
title Axial length targets for myopia control
title_full Axial length targets for myopia control
title_fullStr Axial length targets for myopia control
title_full_unstemmed Axial length targets for myopia control
title_short Axial length targets for myopia control
title_sort axial length targets for myopia control
topic Feature Issue Manuscripts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252804/
https://www.ncbi.nlm.nih.gov/pubmed/33951213
http://dx.doi.org/10.1111/opo.12812
work_keys_str_mv AT chamberlainpaul axiallengthtargetsformyopiacontrol
AT lazondelajarapercy axiallengthtargetsformyopiacontrol
AT arumugambaskar axiallengthtargetsformyopiacontrol
AT bullimoremarka axiallengthtargetsformyopiacontrol